Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $87,019 | 57 | 68.4% |
| Food and Beverage | $31,210 | 932 | 24.5% |
| Travel and Lodging | $6,834 | 57 | 5.4% |
| Consulting Fee | $1,926 | 2 | 1.5% |
| Education | $179.22 | 31 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $55,042 | 140 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $48,913 | 147 | $0 (2022) |
| Amgen Inc. | $5,222 | 67 | $0 (2024) |
| PFIZER INC. | $3,141 | 172 | $0 (2023) |
| GlaxoSmithKline, LLC. | $2,554 | 121 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,842 | 33 | $0 (2023) |
| Novo Nordisk Inc | $1,710 | 81 | $0 (2023) |
| ABBVIE INC. | $1,455 | 61 | $0 (2024) |
| Amarin Pharma Inc. | $1,333 | 34 | $0 (2021) |
| Lilly USA, LLC | $935.24 | 88 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $664.29 | 6 | Amgen Inc. ($374.97) |
| 2023 | $1,908 | 44 | Amgen Inc. ($798.47) |
| 2022 | $2,390 | 78 | Amgen Inc. ($866.80) |
| 2021 | $3,977 | 165 | Amgen Inc. ($766.84) |
| 2020 | $2,939 | 112 | GlaxoSmithKline, LLC. ($448.29) |
| 2019 | $19,652 | 193 | Janssen Pharmaceuticals, Inc ($12,784) |
| 2018 | $34,843 | 184 | SANOFI-AVENTIS U.S. LLC ($20,421) |
| 2017 | $60,794 | 297 | SANOFI-AVENTIS U.S. LLC ($31,705) |
All Payment Transactions
1,079 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $65.22 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Inflammation | ||||||
| 08/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $112.49 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $111.61 | General |
| Category: Opioid Use Disorder | ||||||
| 05/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
| 04/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
| 12/11/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
| 12/11/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/06/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/24/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/18/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
| 09/15/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $5.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/30/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $112.85 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $3.19 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Inflammation | ||||||
| 08/14/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Inflammation | ||||||
| 08/03/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Diabetes | ||||||
| 07/14/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/10/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: Inflammation | ||||||
| 06/26/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
| 06/21/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: RESPIRATORY | ||||||
| 06/05/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 160 | 302 | $82,649 | $16,122 |
| 2022 | 5 | 261 | 493 | $99,147 | $32,806 |
| 2021 | 5 | 360 | 666 | $113,032 | $42,054 |
| 2020 | 10 | 512 | 872 | $137,021 | $45,104 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 247 | $70,507 | $13,707 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 55 | $12,143 | $2,415 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 333 | $65,429 | $21,552 | 32.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 61 | 80 | $18,781 | $6,199 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 47 | $6,242 | $1,850 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $5,279 | $1,726 | 32.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 13 | $3,416 | $1,479 | 43.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 168 | 395 | $67,940 | $25,326 | 37.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 59 | 93 | $21,568 | $10,144 | 47.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 75 | 109 | $13,708 | $4,708 | 34.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 28 | 37 | $4,313 | $1,150 | 26.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 30 | 32 | $5,504 | $725.17 | 13.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 142 | 276 | $47,472 | $12,928 | 27.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 109 | 158 | $27,176 | $9,205 | 33.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 19 | 93 | $15,639 | $7,695 | 49.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 90 | 132 | $15,387 | $3,758 | 24.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 61 | 87 | $10,142 | $3,250 | 32.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 40 | $4,664 | $2,289 | 49.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 32 | 32 | $7,421 | $2,114 | 28.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 14 | $4,584 | $2,029 | 44.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 16 | 20 | $3,462 | $1,701 | 49.1% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 20 | 20 | $1,075 | $135.12 | 12.6% |
About Dr. Bharat Gupta, MD
Dr. Bharat Gupta, MD is a Internal Medicine healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992749410.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bharat Gupta, MD has received a total of $127,168 in payments from pharmaceutical and medical device companies, with $664.29 received in 2024. These payments were reported across 1,079 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($87,019).
As a Medicare-enrolled provider, Gupta has provided services to 1,293 Medicare beneficiaries, totaling 2,333 services with total Medicare billing of $136,086. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Rochester, NY
- Active Since 06/15/2006
- Last Updated 12/23/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1992749410
Products in Payments
- XARELTO (Drug) $39,836
- SOLIQUA (Drug) $32,823
- TOUJEO (Drug) $19,231
- INVOKANA (Drug) $8,851
- Repatha (Biological) $2,348
- ELIQUIS (Drug) $2,334
- DISEASE STATE (Drug) $2,034
- TRELEGY ELLIPTA (Drug) $1,623
- Vascepa (Drug) $1,333
- FARXIGA (Drug) $1,164
- Otezla (Drug) $1,088
- ENTRESTO (Drug) $887.97
- Prolia (Biological) $855.95
- CHANTIX (Drug) $854.64
- UBRELVY (Drug) $781.56
- Aimovig (Biological) $774.23
- EUCRISA (Drug) $706.41
- Ozempic (Drug) $678.40
- TRULICITY (Drug) $589.06
- UTIBRON (Drug) $495.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rochester
Dr. Ben George, M.d, M.D
Internal Medicine — Payments: $729,795
John Kisiel, M.d, M.D
Internal Medicine — Payments: $550,377
Gregory Poland, M.d, M.D
Internal Medicine — Payments: $532,099
Christopher Ritchlin, Md, MD
Internal Medicine — Payments: $512,889
Scott Feitell, D.o, D.O
Internal Medicine — Payments: $471,187
Prashant Kapoor, Md, MD
Internal Medicine — Payments: $403,295